| 2024-02-29 | +76.8% | analyst | TradingView | COCH Forecast — Price Target — Prediction for 2027 - TradingView |
| 2024-03-04 | +48.9% | news | ChartMill | COCH Technical Analysis | Trend, Signals & Chart Patterns | ENVOY MEDICAL INC (NASDAQ:COCH) - ChartMill |
| 2025-10-08 | -40.6% | legal | Seeking Alpha | Envoy Medical secures $4M upfront in direct offering, targets total $16M via warrant exercise |
| 2025-10-08 | -40.6% | news | Stock Titan | Up to $16M funding — Envoy Medical raises $4.0M in registered direct offering with concurrent warrants - Stock Titan |
| 2025-10-08 | -40.6% | news | TipRanks | Why Is Envoy Medical Stock (COCH) Down 35% Today? - TipRanks |
| 2025-10-08 | -40.6% | news | Benzinga | Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acurx Pharma - Benzinga |
| 2023-10-02 | -37.5% | M&A | Seeking Alpha | Envoy Medical shares sink 30% in market debut following SPAC merger |
| 2023-10-02 | -37.5% | news | TradingView | COCH Stock Price and Chart — NASDAQ:COCH - TradingView |
| 2026-02-11 | +35.9% | news | Seeking Alpha | Envoy Medical announces pricing of up to $78M public offering |
| 2026-02-11 | +35.9% | legal | Stock Titan | Hearing implant maker Envoy Medical raises $30M, eyes FDA-tied warrant cash - Stock Titan |
| 2026-02-11 | +35.9% | news | TMX Newsfile | Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering - TMX Newsfile |
| 2025-09-22 | -35.0% | news | Seeking Alpha | Envoy Medical announces $2.5 million registered direct offering priced at-the-market under Nasdaq rules |
| 2026-02-13 | +31.3% | expansion | TradingView | Envoy Medical Signs Multiple Financing Agreements - TradingView |
| 2026-02-17 | +25.5% | news | TMX Newsfile | Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant |
| 2026-02-17 | +25.5% | news | Stock Titan | 45 people receive fully implanted cochlear device in pivotal trial - Stock Titan |
| 2026-02-17 | +25.5% | news | Investing.com South Africa | Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com South Africa |
| 2024-04-02 | +25.1% | news | Seeking Alpha | Envoy Medical reports FY results |
| 2025-10-07 | +15.0% | legal | Stock Titan | 3-Month Results: FDA Expands Envoy Medical's Acclaim Trial to Add 46 Patients; Enrollment Due Early 2026 - Stock Titan |
| 2025-10-07 | +15.0% | legal | Investing.com | Envoy Medical stock soars after FDA approves clinical trial expansion - Investing.com |
| 2025-10-07 | +15.0% | legal | Yahoo Finance | EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial - Yahoo Finance |
| 2025-10-07 | +15.0% | legal | MSN | Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN |
| 2025-10-07 | +15.0% | news | timothysykes.com | COCH Stocks Surge: A Turning Point? - timothysykes.com |
| 2025-10-07 | +15.0% | legal | parameter.io | Envoy Medical, Inc. (COCH) Stock :Soars 111% After FDA Expands Acclaim Cochlear Implant Trial - parameter.io |
| 2026-03-23 | -13.1% | news | TMX Newsfile | Envoy Medical Reports Full Year 2025 Financial Results |
| 2026-03-23 | -13.1% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$1.23, revenue of $0.02M |
| 2026-03-23 | -13.1% | legal | Stock Titan | Envoy's fully implanted cochlear implant trial moves to final FDA stage - Stock Titan |
| 2026-04-01 | +11.6% | news | TMX Newsfile | Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant |
| 2026-04-01 | +11.6% | news | Stock Titan | A fully implanted cochlear implant clears a key 12-month trial step - Stock Titan |
| 2026-04-01 | +11.6% | legal | Stock Titan | COCH SEC Filings - Envoy Medical 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-11-14 | +11.1% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.37 misses by $0.11, revenue of $0.05M misses by $0.02M |
| 2024-11-14 | +11.1% | earnings | Stock Titan | Envoy Medical Advances Cochlear Implant Trial Despite Revenue Drop in Q3 2024 - Stock Titan |
| 2026-03-11 | +8.4% | news | TMX Newsfile | Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant |
| 2026-03-11 | +8.4% | news | Stock Titan | First fully implanted cochlear implant trial hits key U.S. milestone - Stock Titan |
| 2025-03-12 | +8.2% | legal | Seeking Alpha | Envoy medical secures $10 million funding |
| 2026-02-12 | -7.6% | legal | Stock Titan | Hearing implant firm Envoy Medical lines up up to $78M for FDA study - Stock Titan |
| 2023-09-28 | +7.6% | M&A | Seeking Alpha | SPAC Anzu I, Envoy Medical shareholders approve merger deal |
| 2025-05-01 | -7.1% | news | Stock Titan | Envoy Medical's Revolutionary Fully Implanted Cochlear Implant Shows Promise in Latest Clinical Trial Data - Stock Titan |
| 2025-10-27 | -6.7% | news | Stock Titan | Envoy Medical (NASDAQ: COCH) granted Nasdaq listing extension to Feb 23, 2026 after Panel review - Stock Titan |
| 2026-02-19 | -6.7% | news | TMX Newsfile | Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial |
| 2026-02-19 | -6.7% | news | TMX Newsfile | Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - TMX Newsfile |
| 2026-02-19 | -6.7% | news | Stock Titan | Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan |
| 2026-02-19 | -6.7% | news | simplywall.st | Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st |
| 2026-04-13 | +6.5% | earnings | Stock Titan | Envoy Medical (NASDAQ: COCH) amends 10-K, keeps original results - Stock Titan |
| 2026-04-13 | +6.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Envoy Med (COCH) Stock Growing Now | Price at $0.62, Up 2.12% - Most Watched Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-03 | -6.2% | earnings | MarketBeat | Envoy Medical (NASDAQ:COCH) Upgraded to "Hold" at Zacks Research - MarketBeat |
| 2023-11-20 | +6.0% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of $0.13 |
| 2026-03-31 | +6.0% | analyst | MT Newswires | HC Wainwright Initiates Coverage on Envoy Medical With Buy Rating, $2.50 Price Target |
| 2026-03-31 | +6.0% | news | Stock Titan | Auditor change at Envoy Medical (NASDAQ: COCH) after going concern and control weaknesses - Stock Titan |
| 2025-07-31 | -5.2% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.32, revenue of $0.08M |
| 2026-03-27 | -5.2% | news | Stock Titan | Envoy Medical (NASDAQ: COCH) posts 2025 loss, slashes debt and advances Acclaim trial - Stock Titan |
| 2025-12-16 | -5.1% | news | Stock Titan | Envoy Medical (NASDAQ: COCH) adds Australian patent to cochlear implant IP - Stock Titan |
| 2026-02-23 | +4.9% | legal | TMX Newsfile | Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space |
| 2026-02-23 | +4.9% | news | Stock Titan | Three new patents detail Envoy’s fully implanted cochlear tech - Stock Titan |
| 2026-02-23 | +4.9% | legal | TMX Newsfile | Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - TMX Newsfile |
| 2025-04-25 | -4.9% | news | Stock Titan | COCH Stock Price, News & Analysis | Envoy Medical - Stock Titan |
| 2025-12-03 | +4.5% | analyst | Yahoo Finance | Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why - Yahoo Finance |
| 2024-02-12 | +4.5% | earnings | MarketBeat | Envoy Medical (COCH) Short Interest & Short Float | Updated Apr 2026 - MarketBeat |
| 2025-05-11 | -4.4% | news | Intellectia AI | COCH Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2026-04-22 | -4.1% | news | TMX Newsfile | Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant |
| 2026-04-22 | -4.1% | news | Stock Titan | A fully implanted cochlear implant clears key step in 56-patient study - Stock Titan |
| 2024-05-16 | +4.1% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.32 |
| 2024-05-19 | +4.1% | news | Seeking Alpha | Envoy Medical Is Pursuing Filling A Hearing Industry Void |
| 2024-05-19 | +4.1% | news | Seeking Alpha | Envoy Medical Is Pursuing Filling A Hearing Industry Void (NASDAQ:COCH) - Seeking Alpha |
| 2025-11-06 | -3.0% | earnings | Yahoo Finance | Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance |
| 2026-04-16 | -3.0% | executive | TMX Newsfile | Envoy Medical Appoints Chas McKhann to Board of Directors |
| 2026-04-16 | -3.0% | executive | TMX Newsfile | Envoy Medical Appoints Chas McKhann to Board of Directors - TMX Newsfile |
| 2026-04-12 | +2.9% | expansion | marketscreener.com | 28,934,960 Class A Common Stock of Envoy Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-APR-2026. - marketscreener.com |
| 2024-05-11 | -2.8% | earnings | MarketBeat | Envoy Medical (COCH) Stock Forecast and Price Target 2026 - MarketBeat |
| 2025-05-28 | +2.8% | news | Intellectia AI | COCH Forecast — Price Prediction for 2026. Should I Buy COCH? - Intellectia AI |
| 2025-11-10 | -1.8% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.35, revenue of $0.04M |
| 2025-11-10 | -1.8% | earnings | Yahoo Finance | Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2024-04-24 | -1.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Envoy Medical, Inc. (COCH) - Zacks Investment Research |
| 2026-04-20 | +1.7% | news | Cổng thông tin điện tử tỉnh Lào Cai | Is Envoy Med (COCH) stock a buy on dip opportunity (Breakdown Watch) 2026-04-20 - Hot Community Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-12-18 | +1.7% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-05-02 | -1.6% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.29, revenue of $0.04M |
| 2026-02-24 | +1.6% | news | TMX Newsfile | Envoy Medical Regains Compliance with Nasdaq Listing Requirement |
| 2026-02-24 | +1.6% | news | Seeking Alpha | Envoy Medical regains compliance with Nasdaq |
| 2026-02-24 | +1.6% | news | Stock Titan | Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan |
| 2026-04-17 | -1.6% | analyst | Benzinga | Envoy Medical Analyst Ratings and Price Targets | NASDAQ:COCH - Benzinga |
| 2026-04-17 | -1.6% | news | Stock Titan | Envoy Medical (COCH) grants director Chas McKhann 100,000 options - Stock Titan |
| 2026-04-17 | -1.6% | news | Stock Titan | Envoy Medical (COCH) director Chas McKhann files initial Form 3 ownership - Stock Titan |
| 2023-10-04 | -0.6% | earnings | MarketBeat | Envoy Medical (COCH) Stock Price, News & Analysis - MarketBeat |
| 2026-04-02 | -0.6% | news | Stock Titan | Large warrant share vote and plan expansions in Envoy Medical (NASDAQ: COCH) 2026 proxy - Stock Titan |
| 2024-08-13 | +0.3% | earnings | Seeking Alpha | Envoy Medical GAAP EPS of -$0.27 |